Kaituhi: AMAN, M.G

  • Näytä hakutuloksena
  • Tutki tähän liittyviä kanavia
  • Pikavilkaisu
    HALOPERIDOL TREATMENT WITH CHRONICALLY MEDICATED RESIDENTS: DOSE EFFECTS ON CLINICAL BEHAVIOR AND REINFORCEMENT CONTINGENCIES
  • Pikavilkaisu
    ATTITUDES AND KNOWLEDGE OF GERONTOLOGICAL NURSES TOWARD PSYCHOTROPIC DRUGS
  • Pikavilkaisu
    REVIEW OF FENFLURAMINE IN THE TREATMENT OF THE DEVELOPMENTAL DISABILITIES
  • Pikavilkaisu
    PREVALENCE AND PATTERNS OF USE OF PSYCHOACTIVE MEDICINES AMONG INDIVIDUALS WITH AUTISM IN THE AUTISM SOCIETY OF OHIO
  • Pikavilkaisu
    LA ESCALA DE CONDUCTAS ANOMALAS. EN: TRASTORNOS MENTALES Y DE CONDUCTA EN EL RETRASO MENTAL. EVALUACION E INTERVENCION
  • Pikavilkaisu
    CONSIDERATIONS IN THE USE OF PSYCHOTROPIC DRUGS IN ELDERLY MENTALLY RETARDED PERSONS
  • Pikavilkaisu
    OVERVIEW OF PHARMACOTHERAPY:CURRENT STATUS AND FUTURE DIRECTIONS
  • Pikavilkaisu
    DEVELOPMENT OF THE CHILDREN'S SCALE OF HOSTILITY AND AGGRESSION: REACTIVE/PROACTIVE (C-SHARP)
  • Pikavilkaisu
    PSYCHOMETRIC PROPERTIES OF THE CHILDREN'S SCALE OF HOSTILITY AND AGGRESSION: REACTIVE/PROACTIVE (C-SHARP)
  • Pikavilkaisu
    PSYCHOMETRIC CHARACTERISTICS OF THE ABERRANT BEHAVIOR CHECKLIST
  • Pikavilkaisu
    THE ABERRANT BEHAVIOR CHECKLIST: A BEHAVIOR RATING SCALE FOR THE ASSESSMENT OF TREATMENT EFFECTS
  • Pikavilkaisu
    CLINICAL EFFECTS OF METHYLPHENIDATE AND THIORIDAZINE IN INTELLECTUALLY SUBAVERAGE CHILDREN
  • Pikavilkaisu
    PREDICTION OF CLINICAL RESPONSE IN CHILDREN TAKING METHYLPHENIDATE
  • Pikavilkaisu
    METHYLPHENIDATE AND THIORIDAZINE IN THE TREATMENT OF INTELLECTUALLY SUBAVERAGE CHILDREN: EFFECTS ON COGNITIVE-MOTOR PERFORMANCE
  • Pikavilkaisu
    INCIDENTAL LEARNING, DISTRACTION, AND SUSTAINED ATTENTION IN HYPERACTIVE AND CONTROL SUBJECTS
  • Pikavilkaisu
    REVIEW AND EVALUATION OF INSTRUMENTS FOR ASSESSING EMOTIONAL AND BEHAVIOURAL DISORDERS
  • Pikavilkaisu
    PHARMACOTHERAPY IN THE DEVELOPMENTAL DISABILITIES NEW DEVELOPMENTS
  • Pikavilkaisu
    FACTOR VALIDITY AND NORMS FOR THE ABERRANT BEHAVIOR CHECKLIST IN A COMMUNITY SAMPLE OF CHILDREN WITH MENTAL RETARDATION
  • Pikavilkaisu
    FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ATTENTION DEFICIT HYPERACTIVITY DISORDER: LABORATORY EFFECTS
  • Pikavilkaisu
    FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD: CLINICAL AND SIDE EFFECTS
  • Pikavilkaisu
    PREVALENCE OF TOXIC ANTICONVULSANT DRUG CONCENTRATIONS IN MENTALLY RETARDED PERSONS WITH EPILEPSY
  • Pikavilkaisu
    RATINGS OF HYPERACTIVITY AND DEVELOPMENTAL INDICES: SHOULD CLINICIANS CORRECT FOR DEVELOPMENTAL LEVEL?
  • Pikavilkaisu
    THE ABERRANT BEHAVIOR CHECKLIST-COMMUNITY: FACTOR VALIDITY AND EFFECT OF SUBJECT VARIABLES FOR ADULTS IN GROUP HOMES
  • Pikavilkaisu
    PARENT -AND SELF- RATINGS OF ANXIETY IN CHILDREN WITH MENTAL RETARDATION: AGREEMENT LEVELS AND TEST-RETEST RELIABILITY